Efficacy of Yakridari loha in the management of Anemia in Udara( liver cirrhosis).

Prospective single arm open clinical trial to study the efficacy of Yakridari Loha in the manangement of Pandu in Udara with special reference to Anemia in Liver Cirrhosis. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071154

Enrollment

Registered

2024-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having cardinal signs and symptoms of Pandu in Udara as per ayurvedic texts without any bar of caste, sex and religion. 2.Patients having Haemoglobin level between 5 to 12gm%.

Exclusion criteria

Exclusion criteria: 1.Chidrodar 2.Acute MI 3.Malignancy 4.Pregnancy 5.Hepatic Encephalopathy 6.SLE 7.Recent MI 8.Patient in condition of precoma and coma(Overt & Covert Coma) 9.HIV & HBsAg positive patients 10.Complicated Liver Disorders with ascites 11.Congenital & hereditary disorders. 12.Metabolic Disorders like Myxedema, Thyroid etc

Design outcomes

Primary

Measure	Time frame
To evaluate the hematinic effect of Yakridari Loha in Pandu in UdaraTimepoint: 21 days	—

Secondary

Measure	Time frame
1.To evaluate the hematinic effect of Yakridari Loha in Pandu in Udara Timepoint: 7th day, 14th day & 21st day;2.To study the adverse effects of Yakridari Loha, If any.Timepoint: 7th, 14th & 21st day.	—

Countries

India

Contacts

Public ContactDr Farheenben Vohra

Seth Chandalmal Mutha Aryangla Vaidyak Mahavidyalaya, Satara

drpdlondhe4@gmail.com9422435765

Outcome results